Literature DB >> 2904840

The onset of ablation of the evoked adductor pollicis muscle twitch in children: a clinical perspective.

P I Reynolds1, W B Fang, A F VanDerSpek.   

Abstract

The time to loss of the adductor pollicis muscle response to ulnar nerve stimulation at 1 Hz (twitch) after succinylcholine, 1.5 mg.kg-1 intravenously (IV), or vecuronium, 0.1 mg.kg-1 (IV), administration was assessed visually in 134 children, age 2-13 yr, during clinically determined, deep halothane, enflurane and isoflurane anaesthesia. The overall time to twitch ablation and duration of succinylcholine's action is in agreement with published times obtained under controlled experimental conditions; the onset time following vecuronium is comparable to those observed during a similar anaesthetic background measured under controlled experimental conditions. Twitch ablation after succinylcholine was achieved in half the time needed following vecuronium regardless of anaesthetic agent. Succinylcholine's and vecuronium's onset time as well as succinylcholine's duration is adequately assessed by the outlined, simple clinical means. The choice of inhalation agent does not affect the time to visible twitch ablation in a clinically relevant manner; nor does it make an appreciable difference, in clinical terms, in succinylcholine's duration of action.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904840     DOI: 10.1007/BF03020343

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  21 in total

1.  [Isoflurane in pediatric anesthesia].

Authors:  J Hausdörfer; H Hagemann; M Bell; M Mertinat
Journal:  Anaesthesist       Date:  1986-06       Impact factor: 1.041

2.  Neuromuscular blocking effects of succinylcholine in infants and children.

Authors:  D R Cook; C G Fisher
Journal:  Anesthesiology       Date:  1975-06       Impact factor: 7.892

3.  Comparison of speed of onset of fazadinium, pancuronium, tubocurarine and suxamethonium.

Authors:  C L Blackburn; M Morgan
Journal:  Br J Anaesth       Date:  1978-04       Impact factor: 9.166

4.  Onset and recovery of atracurium and suxamethonium-induced neuromuscular blockade with simultaneous train-of-four and single twitch stimulation.

Authors:  M J Curran; F Donati; D R Bevan
Journal:  Br J Anaesth       Date:  1987-08       Impact factor: 9.166

5.  The cardiovascular effects of a new inhalation anesthetic, Forane, in human volunteers at constant arterial carbon dioxide tension.

Authors:  W C Stevens; T H Cromwell; M J Halsey; E I Eger; T F Shakespeare; S H Bahlman
Journal:  Anesthesiology       Date:  1971-07       Impact factor: 7.892

6.  Comparative neuromuscular effects of pancuronium, gallamine, and succinylcholine during forane and halothane anesthesia in man.

Authors:  R D Miller; W L Way; W M Dolan; W C Stevens; E I Eger
Journal:  Anesthesiology       Date:  1971-11       Impact factor: 7.892

7.  Cardiovascular effects of halothane in man.

Authors:  E I Eger; N T Smith; R K Stoelting; D J Cullen; L B Kadis; C E Whitcher
Journal:  Anesthesiology       Date:  1970-05       Impact factor: 7.892

Review 8.  Isoflurane: a review.

Authors:  E I Eger
Journal:  Anesthesiology       Date:  1981-11       Impact factor: 7.892

9.  Neuromuscular effects of vecuronium (ORG NC45) in infants and children during N2O, halothane anesthesia.

Authors:  D M Fisher; R D Miller
Journal:  Anesthesiology       Date:  1983-06       Impact factor: 7.892

10.  Safety and efficacy of vecuronium in adolescents and children.

Authors:  N G Goudsouzian; J J Martyn; L M Liu; M Gionfriddo
Journal:  Anesth Analg       Date:  1983-12       Impact factor: 5.108

View more
  1 in total

1.  DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites.

Authors:  C F Bartels; F S Jensen; O Lockridge; A F van der Spek; H M Rubinstein; T Lubrano; B N La Du
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.